Back
Brainstorm Cell Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
9
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.78
Seasonality Move:
11.28%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
Brainstorm Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.94 | Sell |
| 20-day SMA: | 2.07 | Sell |
| 50-day SMA: | 3.23 | Sell |
| 200-day SMA: | 5.54 | Sell |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 2.23 | Sell |
| 50-day EMA: | 3.06 | Sell |
| 200-day EMA: | 6.33 | Sell |
Brainstorm Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 30.33 | Sell |
| Chaikin Money Flow: | -9175 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.72) | Sell |
| Bollinger Bands (100): | (2.9 - 5.72) | Sell |
Brainstorm Cell Therapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics Stock
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 1.86 while BCLI 8-day simple moving average is 1.94, which is a Sell signal.
- The stock price of BCLI is 1.86 while Brainstorm Cell Therapeutics 20-day SMA is 2.07, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day simple moving average is 3.23 while BCLI share price is 1.86, making it a Sell technically.
- BCLI stock price is 1.86 and Brainstorm Cell Therapeutics 200-day simple moving average is 5.54, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
9
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy or a Sell?
-
Brainstorm Cell Therapeutics stock is rated a Sell
The current Brainstorm Cell Therapeutics [BCLI] share price is $1.86. The Score for BCLI is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics Stock Info
Market Cap:
9.89M
Price in USD:
1.86
Share Volume:
33.72K
Brainstorm Cell Therapeutics 52-Week Range
52-Week High:
11.89
52-Week Low:
1.81
Sell
9
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Brainstorm Cell Therapeutics Share Price Forecast
-
What is the Brainstorm Cell Therapeutics stock price today?
The Brainstorm Cell Therapeutics stock price is 1.86 USD today. -
Will BCLI stock go up or go down?
Brainstorm Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Brainstorm Cell Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics is overvalued.
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 1.86 while BCLI 8-day exponential moving average is 1.96, which is a Sell signal.
- The stock price of BCLI is 1.86 while Brainstorm Cell Therapeutics 20-day EMA is 2.23, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day exponential moving average is 3.06 while BCLI share price is 1.86, making it a Sell technically.
- BCLI stock price is 1.86 and Brainstorm Cell Therapeutics 200-day simple moving average is 6.33, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics
Is Brainstorm Cell Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Technical Analysis of Brainstorm Cell Therapeutics
Should I short Brainstorm Cell Therapeutics stock?
- BCLI Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Brainstorm Cell Therapeutics is a Sell
- Brainstorm Cell Therapeutics Relative Strength Index (RSI) is 30.33, which suggest Brainstorm Cell Therapeutics is oversold
- The Bollinger Bands (25) for Brainstorm Cell Therapeutics is (1.82 - 2.72), which suggest Brainstorm Cell Therapeutics is a Sell
- The Bollinger Bands (100) for Brainstorm Cell Therapeutics is (2.9 - 5.72), which suggest Brainstorm Cell Therapeutics is a Sell
* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.